hesperetin has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Hu, Z; Ma, K; Wang, H; Wang, J | 1 |
| Alshatwi, AA; Periasamy, VS; Ramesh, E; Subash-Babu, P | 1 |
2 other study(ies) available for hesperetin and Cancer of Cervix
| Article | Year |
|---|---|
Hesperetin regulates transforming growth factor-β1/Smads pathway to suppress epithelial-mesenchymal transition -mediated invasion and migration in cervical cancer cell.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; HeLa Cells; Hesperidin; Humans; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Uterine Cervical Neoplasms | 2021 |
The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; fas Receptor; Female; Flow Cytometry; Hesperidin; Humans; In Situ Nick-End Labeling; Inhibitory Concentration 50; Membrane Potential, Mitochondrial; Mitochondria; Real-Time Polymerase Chain Reaction; Time Factors; Uterine Cervical Neoplasms | 2013 |